Trial Profile
Phase I/II study on the safety and pharmacokinetics of FIT039 administered by single adhesive skin patch application for the cases of human papillomavirus verrucae
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs FIT 039 (Primary)
- Indications Warts
- Focus Adverse reactions
- 04 Oct 2018 Results published in the Clinical Drug Investigation
- 19 May 2017 New trial record